Gene expression profiles in hepatocellular carcinoma: Not yet there

Journal of Hepatology

Volumn 41, Issue 2, 2004, Pages 336-339

  Llovet, Josep M ^a,b   Wurmbach, Elisa ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CYTOSTATIC AGENT; GEFITINIB; IMATINIB; MOLECULAR MARKER; PROTEIN TYROSINE KINASE INHIBITOR;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER STAGING; CARCINOGENESIS; EDITORIAL; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS;

EID: 4444309826     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.002     Document Type: Editorial

References (32)

1. Bruix J., Boix L., Sala M., Llovet J.M. Focus on hepatocellular carcinoma. Cancer Cell. 5:2004;215-219
2. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet. 362:2003;1907-1917
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 94:2001;153-156
4. Sangiovanni A., Del Ninno E., Fasani P., De Fazio C., Ronchi G., Romeo R., et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 126:2004;1005-1014
5. Hanahan D., Wienberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
6. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., et al. A census of human cancer genes. Nat Rev Cancer. 4:2004;177-183
7. Ramaswamy S. Translating cancer genomics into clinical oncology. N Engl J Med. 350:2004;1814-1816
8. Liu E., Karuturi K. Microarrays and clinical investigations. N Engl J Med. 350:2004;1595-1597
9. Ntzani E., Ioannidis J. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet. 362:2003;1439-1444
10. Grimwade D., Haferlach T. Gene-expression profiling in acute myeloid leukemia. N Engl J Med. 350:2004;1676-1678
11. Van de Vijver M.J., He Y.D., Van't Veer L.J. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:2002;1999-2009
12. Lossos I., Czerwinski D., Alizadeh A., Wechser M., Tibshirani R., Botstein D., et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 350:2004;1828-1837
13. Capdeville R., Buchdunger E., Zimmermann J., Matter A. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov. 1:2002;493-502
14. Muhsin M., Graham J., Kirkpatrick P. Gefitinib. Nat Rev Cancer. 3:2003;556-557
15. Ferrara N., Hillan K., Gerber H.P., Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 3:2004;391-400
16. Millar A., Lynch K. Rethinking clinical trials for cytostatic drugs. Nat Rev Cancer. 3:2003;540-545
17. Thorgeirsson S., Grisham J. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 31:2002;339-346
18. Smith M., Yue Z., Korth M., Do H.A., Boix L., Fausto N., et al. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology. 38:2003;1458-1467
19. Anders R.A., Yerian L.M., Tretiakova M., Davison J.M., Quigg R.J., Domer P.H., et al. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol. 162:2003;991-1000
20. Paradis V., Bièche I., Dargère D., Laurendeau I., Laurent C., Bioulac P., et al. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach. Am J Pathol. 163:2003;733-741
21. Okabe H., Satoh S., Kato T., Kitahara O., Yanagawa R., Yamaoka Y., et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61:2001;2129-2137
22. Delpuech O., Trabut J.B. Carnot F Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene. 21:2002;2926-2937
23. Iizuka N., Oka M. Yamada-Okabe Hizuka Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 62:2002;3939-3944
24. Smith M.W., Yue Z.N., Geiss G.K., Sadovnikova N.Y. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res. 63:2003;859-864
25. Ye Q.H., Qin L.X., Forgues M. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 9:2003;416-423
26. Iizuka N., Oka M., Yamada-Okabe H., Nishida M., Maeda Y., Mori N., et al. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 361:2003;923-929
27. Kurokawa Y., Matoba R., Takemasa I., Nagano H., Dono K., Nakamori S., et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol. 41:2004;284-291
28. Thorgeirsson S. Molecular pathogenesis of hepatocellular carcinoma. Hepatocellular carcinoma: screening, diagnosis and management. NIH-NCI conference on HCC-2004 booklet. 2004
29. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 35:2001;421-430
30. Llovet J.M., Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol. 38:2003;S136-S149
31. Cheung S.T., Chen X., Guan X.Y., Wong S.Y., Tai L.S., Ng I.O., et al. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res. 15:2002;4711-4721
32. Kato K. Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. Nucleic Acid Res. 25:1997;4694-4696